Claritin, Alavert, Advil Allergy Sinus Head Major OTC Approvals In 2002
This article was originally published in The Tan Sheet
Executive Summary
Antihistamines accounted for the most prominent OTC approvals in 2002, with Schering-Plough Healthcare Products' Claritin franchise and Wyeth Consumer Healthcare's Alavert and Advil Allergy Sinus all receiving the FDA go-ahead during the year
You may also be interested in...
OTC Labeling Adopted By FDA In Forced Switch Would Violate Regs Comments Say
FDA could not adopt a drug's approved OTC label from another country as acceptable U.S. OTC labeling without violating its own regulations, according to the American Association of Physicians & Surgeons and Competitive Enterprise Institute
Wyeth’s One-Two Allergy Punch: Advil Allergy Sinus To Join Alavert
Wyeth Consumer Healthcare received FDA approval for its Advil Allergy Sinus on Dec. 19, the same day it received the agency go-ahead to market its non-sedating antihistamine Alavert
Schering OTC Claritin Coupons Appearing In Newspapers Dec. 15
Schering-Plough is offering consumers free samples of Claritin through a new Web site that became operational shortly after the drug's OTC approval